EGFR and breast carcinoma: As shown in Fig. 6h, AJAP1/EGFR KD group improved the tumor growth and weight, β-catenin nuclear expression and the expressions of C-myc and CyclinD1 compared with the other two groups isolated from the breast cancer cell-inoculated nude mice.